Aspira Women’s Health Appoints John Ragard to Board
Company Announcements

Aspira Women’s Health Appoints John Ragard to Board

Aspira Women’s Health (AWH) just unveiled an update.

Aspira Women’s Health Inc. welcomes John Ragard to its Board of Directors, effective July 25, 2024. With 46 years of financial expertise, including roles as a venture capital investor and a portfolio manager with a track record of outperforming benchmarks, Ragard brings a wealth of knowledge to the team. His tenure will last until the 2025 annual meeting of stockholders, a move initiated by significant stockholder Jack W. Schuler under a 2013 agreement.

See more insights into AWH stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAspira Women’s Health Engages Investors with Performance Insights
TheFlyAspira Women’s Health announces publication of data on blood test
GlobeNewswireAspira Women’s Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App